Zhiyun Hou

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

H. Xiang, Yan Yan, Wenhong Zhang, 2021, Clinical Gastroenterology and Hepatology.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.

Xiaoxiong Zeng, Hong Ye, Yi Sun, 2008, Journal of agricultural and food chemistry.

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

Xia Li, J. Fallowfield, D. Rockey, 2021, Journal of Hepatology.

MiR-597-5p suppresses the progression of hepatocellular carcinoma via targeting transcriptional enhancer associate domain transcription factor 1 (TEAD1)

Zhiyun Hou, Xiaogang Sun, Shuangwei Zhang, 2022, In Vitro Cellular & Developmental Biology - Animal.

Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

H. Xiang, Xianghui Qi, Chuan Liu, 2022, Journal of medical virology.